Monthly Archives: May, 2023

Browse our exclusive articles!

Roll utilizing generative AI for recreating dolly shots and other cinematic effects

Former Box VP of product management, Faizan Buzdar, has launched Roll - a game-changing video production app that uses creative AI tools to produce high-quality videos. Ideal for influencers, podcasters, and businesses, the app creates multi-camera perspectives with simulated movements and generates revenue by charging in-house corporate marketing and video teams.

Increasing Fraud Troubles UK and EU

Digital fraud is on the rise in the UK and Europe, with deepfakes and forced verification making up a larger percentage of cases. AI technology has led to an increase in deepfake use by criminals, while printed forgeries have dropped. Sumsub has been instrumental in uncovering these trends and offers verification services to help businesses fend off fraud.

Clalit Health Services to Enhance Patient Care with AI and Machine Learning

Clalit Health Services partners with Cloudera to enhance medical services using AI and machine learning. Real-time analysis and automation will improve patient outcomes.

OpenAI’s Cautionary Tale Reveals Fragility of EU Regulatory Dominance

OpenAI considers discontinuing EU business after new AI regulation adopted. AI regulation collisions could be catastrophic, and US-EU misalignment may lead to a fragmented regulatory landscape. CEO Sam Altman denies plans but stresses the need for continued dialogue on AI regulations. #AIregulation

EU Commission Issues Internal Guidelines on ChatGPT Generative AI

The European Commission cautions employees on the risks of using online generative AI models such as ChatGPT and Bard. Guidelines are reviewed regularly to ensure compliance with the EU's AI Act.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img